Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled growth hormone study in children with Prader-Willi syndrome
NL-OMON26880Active, not recruiting
- Sponsor
- Pfizer
- Start
- Apr 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin in Prader-Willi syndrome (PWS) (4 arms), sponsored by Pfizer. Primary endpoints: Height, Weight and 11 more. Started Apr 2002; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NL-OMON26880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26880.